Company / Interest Expense
ANAPTYSBIO, INC Interest Expense History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$1.0M
FY2021
5-year range
$1.0M / $1.0M
FY2017-FY2021
Trend
-37.0%
vs FY2020
Sector context
#37 of 44
Health Care
What the data says
ANAPTYSBIO, INC's interest expense of $1M is lower than 84% of companies in the Health Care sector (FY2021). Improved from $2M to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2021 with a 5-year CAGR of +17.8%.
Improved from $2M to $1M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -14.3%
- 5-Year CAGR
- +17.8%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 44This company $1.0M Sector average $291.0M
▼
-99.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.8%, indicating consistent growth.
- In FY2021, interest expense decreased 37.0% year-over-year.
- Ranks #37 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $1.0M | -37.0% |
| FY2020 | $1.7M | -6.9% |
| FY2019 | $1.8M | +7.4% |
| FY2018 | $1.7M | +259.1% |
| FY2017 | $460.0K | +0.4% |
| FY2016 | $458.0K | -0.4% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026